Published in Methods Mol Med on January 01, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol (1999) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol (2001) 1.66
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg (1991) 1.61
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50
Malignant melanoma and pregnancy. Cancer (1985) 1.47
Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol (1995) 1.42
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol (1998) 1.38
Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg (2001) 1.28
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery (2001) 1.26
The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg (1999) 1.14
Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol (1997) 1.12
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg (1996) 1.09
Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet (1983) 1.06
Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am (1999) 1.06
Lymphoscintigraphy in malignant melanoma. Ann Plast Surg (1992) 1.04
Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res (1995) 1.04
Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg (1990) 1.03
Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol (1997) 1.01
Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol (1996) 1.01
Malignant melanoma in black American and white American populations. A comparative review. JAMA (1982) 0.99
Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol (1996) 0.99
Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma. Ann Surg Oncol (1998) 0.98
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97
Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control (2000) 0.95
Radiologic, endoscopic and surgical considerations of malignant melanoma metastatic to the small intestine. Curr Surg (1984) 0.94
Learning curves and certification for breast cancer lymphatic mapping. Surg Oncol Clin N Am (1999) 0.93
Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. Ann Plast Surg (1997) 0.92
Sex related survival differences in instances of melanoma. Surg Gynecol Obstet (1984) 0.92
Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol (1997) 0.90
Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park) (1998) 0.90
Lymphoscintigraphy for malignant melanoma. Surgical considerations. Am Surg (1983) 0.89
Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg (2000) 0.89
Imprint cytology of needle-localized breast lesions. Acta Cytol (1993) 0.88
Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol (2001) 0.88
Utility of internal mammary lymph node removal when noted by intraoperative gamma probe detection. Ann Surg Oncol (2001) 0.87
The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol (1999) 0.86
Fine needle aspiration biopsy of palpable breast lesions. Review and statistical analysis of 1875 cases. Surg Oncol (1993) 0.86
Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol (1998) 0.86
Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am J Surg (2001) 0.85
The concept of lymph node dissections in patients with malignant melanoma. Ann Plast Surg (1992) 0.85
Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg (1999) 0.85
Cytology of lumpectomy specimens. Acta Cytol (1991) 0.85
Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Ann Plast Surg (1992) 0.84
The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann Surg Oncol (2001) 0.84
Role of fine needle aspiration cytology after lumpectomy. Acta Cytol (1995) 0.83
Sentinel lymphadenectomy: a safe answer to less axillary surgery? Recent Results Cancer Res (1998) 0.83
The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg (1994) 0.83
Importance of missed axillary micrometastases in breast cancer patients. Breast J (2002) 0.83
Immunodiagnosis of tumors in vivo using radiolabeled monoclonal antibody A2B5. J Surg Oncol (1983) 0.81
The process of clinical trials: a model for successful clinical trial participation. Oncol Nurs Forum (2001) 0.81
Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg (1997) 0.81
Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg (1998) 0.81
The current management and prognosis of acral lentiginous melanoma. Ann Plast Surg (1992) 0.81
Cytochemistry of sex steroid receptors: a critique. Breast Cancer Res Treat (1981) 0.81
Detection of occult lymph node metastases in malignant melanoma. Ann Plast Surg (1992) 0.79
Breast cancer patients' personality style, age, and treatment decision making. J Surg Oncol (1996) 0.79
Lymphatic mapping in breast cancer. Hematol Oncol Clin North Am (1999) 0.78
Techniques for lymphatic mapping in breast carcinoma. Surg Oncol Clin N Am (1999) 0.78
Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg (1992) 0.78
Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Ann Surg Oncol (1997) 0.78
Breast cancer screening in childhood cancer survivors. Med Pediatr Oncol (2000) 0.78
Role of lymphatic mapping and sentinel node biopsy in the detection of melanoma nodal metastases. Eur J Cancer (1998) 0.77
Cutaneous melanoma of the head and neck: advances in evaluation and treatment. Plast Reconstr Surg (2000) 0.77
Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol (1998) 0.77
The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg Am (1997) 0.77
Malignant melanoma in the American black. Curr Surg (1983) 0.76
Metastatic melanoma with an unknown primary. Ann Plast Surg (1992) 0.76
The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc (1997) 0.76
Controversial topics in breast lymphatic mapping. Semin Oncol (2004) 0.76
Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Ann Plast Surg (1992) 0.76
Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol (1997) 0.76
Treatment of the primary in malignant melanoma of the skin. Ann Plast Surg (1992) 0.75
Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma. Ann Surg Oncol (2000) 0.75